AAUM (Average Assets Under Management) of ₹166.25 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.5% | 77.8% | ▲ +0.3% |
| Healthcare Services | 21.5% | 21.3% | ▼ -0.3% |
| Healthcare Equipment & Supplies | 1.0% | 1.0% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.8% | 78.9% | ▲ +1.1% |
| Healthcare Services | 21.3% | 20.3% | ▼ -1.0% |
| Healthcare Equipment & Supplies | 1.0% | 1.0% | ● +0.0% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Aurobindo Pharma Limited ₹15.68 Cr |
Pharmaceuticals & Biotechnology | 6.68% | 7.16% | +0.48% |
| 2 | Glenmark Pharmaceuticals Limited ₹12.32 Cr |
Pharmaceuticals & Biotechnology | 5.14% | 5.62% | +0.48% |
| 3 | Neuland Laboratories Limited ₹6.55 Cr |
Pharmaceuticals & Biotechnology | 2.51% | 2.99% | +0.48% |
| 4 | Laurus Labs Limited ₹24.59 Cr |
Pharmaceuticals & Biotechnology | 10.79% | 11.22% | +0.43% |
| 5 | IPCA Laboratories Limited ₹9.05 Cr |
Pharmaceuticals & Biotechnology | 3.71% | 4.13% | +0.42% |
| 6 | Gland Pharma Limited ₹7.59 Cr |
Pharmaceuticals & Biotechnology | 3.05% | 3.46% | +0.41% |
| 7 | Sai Life Sciences Limited ₹6.65 Cr |
Pharmaceuticals & Biotechnology | 2.77% | 3.03% | +0.26% |
| 8 | GlaxoSmithKline Pharmaceuticals Limited ₹4.17 Cr |
Pharmaceuticals & Biotechnology | 1.68% | 1.90% | +0.22% |
| 9 | Piramal Pharma Limited ₹4.40 Cr |
Pharmaceuticals & Biotechnology | 1.86% | 2.01% | +0.15% |
| 10 | Global Health Limited ₹4.18 Cr |
Healthcare Services | 1.84% | 1.91% | +0.07% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Lupin Limited ₹17.54 Cr |
Pharmaceuticals & Biotechnology | 8.96% | 8.01% | -0.95% |
| 2 | Alkem Laboratories Limited ₹10.29 Cr |
Pharmaceuticals & Biotechnology | 5.14% | 4.70% | -0.44% |
| 3 | Fortis Healthcare Limited ₹15.60 Cr |
Healthcare Services | 7.52% | 7.12% | -0.40% |
| 4 | Aster DM Healthcare Limited ₹6.32 Cr |
Healthcare Services | 3.18% | 2.88% | -0.30% |
| 5 | Krishna Institute Of Medical Sciences Limited ₹6.46 Cr |
Healthcare Services | 3.19% | 2.95% | -0.24% |
| 6 | Biocon Limited ₹9.70 Cr |
Pharmaceuticals & Biotechnology | 4.64% | 4.43% | -0.21% |
| 7 | Abbott India Limited ₹4.44 Cr |
Pharmaceuticals & Biotechnology | 2.21% | 2.03% | -0.18% |
| 8 | Narayana Hrudayalaya Limited ₹4.35 Cr |
Healthcare Services | 2.14% | 1.98% | -0.16% |
| 9 | Mankind Pharma Limited ₹9.04 Cr |
Pharmaceuticals & Biotechnology | 4.27% | 4.13% | -0.14% |
| 10 | Onesource Specialty Pharma Limited ₹3.94 Cr |
Pharmaceuticals & Biotechnology | 1.94% | 1.80% | -0.14% |
30 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹24.59 Cr |
Pharmaceuticals & Biotechnology |
11.22%
|
|
| 2 |
₹17.54 Cr |
Pharmaceuticals & Biotechnology |
8.01%
|
|
| 3 |
₹15.68 Cr |
Pharmaceuticals & Biotechnology |
7.16%
|
|
| 4 |
₹15.60 Cr |
Healthcare Services |
7.12%
|
|
| 5 |
₹12.32 Cr |
Pharmaceuticals & Biotechnology |
5.62%
|
|
| 6 |
₹10.29 Cr |
Pharmaceuticals & Biotechnology |
4.70%
|
|
| 7 |
₹9.70 Cr |
Pharmaceuticals & Biotechnology |
4.43%
|
|
| 8 |
₹9.04 Cr |
Pharmaceuticals & Biotechnology |
4.13%
|
|
| 9 |
₹9.05 Cr |
Pharmaceuticals & Biotechnology |
4.13%
|
|
| 10 |
₹7.59 Cr |
Pharmaceuticals & Biotechnology |
3.46%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.